Breaking News Instant updates and real-time market news.

FNSR

Finisar

$19.70

-0.035 (-0.18%)

, CIEN

Ciena

$31.63

0.33 (1.05%)

07:45
09/13/18
09/13
07:45
09/13/18
07:45

Morgan Stanley goes to Equal Weight on optical, downgrades Finisar and Ciena

As previously reported, Morgan Stanley analyst Meta Marshall downgraded Finisar (FNSR) and Ciena (CIEN), both to Equal Weight from Overweight, as she adjusted her Optical Scorecard following the earnings reports from companies in the sector. The two stocks have closed the short-term valuation gaps that she previously believed existed with their respective moves up of about 35% since April for Finisar and 25% since June for Ciena, Marshall tells investors. The analyst added that she is being cautious ahead of Ciena's FY19 guidance, though she raised her price target on the stock to $32 from $30. Marshall, who keeps a $20 price target on Finisar shares, said she thinks its catalysts don't come until calendar 2019. The analyst also noted that with these two downgrades, she is now Equal Weight on the space as a whole, as she also has Equal Weight ratings on Lumentum (LITE), II-VI (IIVI) and Acacia Communications (ACIA).

FNSR

Finisar

$19.70

-0.035 (-0.18%)

CIEN

Ciena

$31.63

0.33 (1.05%)

LITE

Lumentum

$60.70

-0.65 (-1.06%)

IIVI

II-VI

$46.90

-0.15 (-0.32%)

ACIA

Acacia Communications

$40.07

-0.1 (-0.25%)

  • 13

    Sep

  • 13

    Sep

  • 25

    Sep

  • 01

    Oct

  • 02

    Oct

FNSR Finisar
$19.70

-0.035 (-0.18%)

09/13/18
MSCO
09/13/18
DOWNGRADE
MSCO
Equal Weight
Finisar downgraded to Equal Weight from Overweight at Morgan Stanley
09/07/18
PIPR
09/07/18
NO CHANGE
Target $26
PIPR
Overweight
Piper continues to like setup for Finisar after 'impressive' results
Piper Jaffray analyst Troy Jensen says Finisar reported "impressive" July quarter results with modest revenue upside, better than expected gross margins and upside to earnings. The analyst continues to like the setup for Finisar and believes improving demand trends, coupled with easy comps, should reaccelerate revenue growth through the remainder of 2018 and into 2019. He reiterates an Overweight rating on the shares with a $26 price target.
09/07/18
LOOP
09/07/18
NO CHANGE
Target $20
LOOP
Hold
Finisar price target lowered to $20 from $22 at Loop Capital
Loop Capital analyst James Kisner lowered his price target on Finisar (FNSR) to $20 and kept his Hold rating, saying that while the company's Q1 results were "solid", its Q2 guidance was mixed with lower than expected revenue outlook. The analyst notes that even as the company continues to plan to ramp up its 3D sensing revenue, the management has acknowledged that its outlook is based on the qualification with its largest 3D sensing customer Apple (AAPL). Kisner further cites the "tough competitive environment in datacom optics and execution risk around 3D sensing".
08/29/18
MKMP
08/29/18
NO CHANGE
Target $22
MKMP
Buy
Finisar may be faced with 'period of consolidation', says MKM Partners
MKM Partners analyst Michael Genovese is keeping his Buy rating and $22 price target on Finisar ahead of its Q1 earnings next week, but warns that the stock may be "due for a period of consolidation" following a 22% move higher last month. The analyst states that while the quarter has been a positive for the industry, Finisar's outlook may prove to be disappointing because of its "3D VCSEL revenues, 3D VCSEL capacity ramp timing, and overall corporate gross margins". Genovese also anticipates "ongoing weakness" in Finisar's 3D Sensing and 100G business pricing and margins.
CIEN Ciena
$31.63

0.33 (1.05%)

08/31/18
MKMP
08/31/18
NO CHANGE
Target $36
MKMP
Buy
Ciena price target raised to $36 from $32 at MKM Partners
MKM Partners analyst Michael Genovese raised his price target on Ciena to $36 and kept his Buy rating after its "strong" Q3 results that saw revenues, earnings, and gross margins exceed expectations. The analyst cites Ciena's book-to-bill ratio above parity and backlog at record levels, noting that the company is best positioned to outperform in the Optical / Communications Systems space. Genovese adds that the "global demand for Optical capacity is broad-based" and expects the Telco arena performance to remain strong in 2019 with the launch of 5G connectivity.
09/13/18
MSCO
09/13/18
DOWNGRADE
MSCO
Equal Weight
Ciena downgraded to Equal Weight from Overweight at Morgan Stanley
09/05/18
ARGS
09/05/18
NO CHANGE
Target $38
ARGS
Buy
Ciena price target raised to $38 from $33 at Argus
Argus analyst Jim Kelleher raised his price target on Ciena to $38 and kept his Buy rating after its stronger than expected Q3 results and Q4 guidance. The analyst notes that the quarter was driven by a "healthy bounce-back" in spending by tier-one mobile carriers which helped to support Ciena's margin recovery. Kelleher also states that the company's valuation remains attractive, with the stock trading at a 20.0-times two-year forward PE - below the 5-year historical average of 23.7-times.
08/31/18
JEFF
08/31/18
NO CHANGE
Target $38
JEFF
Buy
Jefferies says don't sell Ciena, ups price target to $38
Jefferies analyst George Notter raised his price target for Ciena to $38 saying yesterday's July quarter results reinforced his view that the company's "perceived margin issues are normal and temporary in nature." The stock is "too cheap" given Ciena's faster earnings growth and improving consistency, Notter tells investors in a post-earnings research note titled "All Roads Lead to Ciena-Don't Sell Here...Reiterate Buy." The analyst calls the company the "long-term market share consolidator in the space."
LITE Lumentum
$60.70

-0.65 (-1.06%)

08/13/18
PIPR
08/13/18
NO CHANGE
Target $9.35
PIPR
Neutral
Oclaro combination with Lumentum creates 'powerhouse,' says Piper Jaffray
Piper Jaffray analyst Troy Jensen says Oclaro (OCLR) this morning "reported another quarter of impressive results and continues the string of solid execution." The company's combination with Lumentum (LITE) will make a "powerhouse in optics with industry leading technology and market share," Jensen tells investors in a post-earnings research note. He keeps a Neutral rating Neutral on Oclaro given the pending acquisition by Lumentum.
08/09/18
MKMP
08/09/18
NO CHANGE
Target $78
MKMP
Buy
Lumentum price target lowered to $78 from $84 at MKM PartnersII-VI
MKM Partners analyst Michael Genovese lowered his price target on Lumentum (LITE) to $78 to reflect the 5% decline in the stock price after its Q4 results prompted investor concerns around 3D VCSEL market share loss to other vendors such as Finisar (FNSR) and II-VI (IIVI). The analyst keeps his Buy rating however, noting that Lumentum remains "very far" ahead of the competition, while the growth of the market can support up to 3 competitors for the company in the long term. Genovese expects Lumentum to be the front-runner to achieve 3D VCSEL market share of over 50%.
09/04/18
JPMS
09/04/18
NO CHANGE
JPMS
Neutral
JPMorgan sees upside to Lumentum estimates from world facing applications
JPMorgan analyst Samik Chatterjee says channel checks done by his firm's Asia Technology team are pointing to an increasing likelihood of adoption of time-of-flight based 3D sensing on the rear of Apple's (AAPL) OLED iPhone models starting in 2019. The use of 3D sensing modules in the rear of the smartphone would be for augmented reality applications, and offer higher accuracy than often discussed camera-based stereo vision approach, Chatterjee tells investors in a research note. He sees upside to his earnings estimates for Lumentum (LITE) from potential fruition of the feedback he's receiving from the channel checks. However, the analyst wants to wait for further clarity relative to market share evolution for the VCSEL supply base before changing his estimates. As such, Chatterjee keeps a Neutral rating on Lumentum with an $80 price target.
09/05/18
NEED
09/05/18
NO CHANGE
Target $90
NEED
Strong Buy
Lumentum price target raised to $90 from $80 at Needham
Needham analyst Alex Henderson raised his price target on Lumentum (LITE) to $90 and kept his Strong Buy rating, saying the company is the "strongest" name in the Optical space even though its valuation is the "lowest". Henderson notes that demand in Optical market is accelerating and 3D "looks set to blossom", even as the stock trades at "just 11.5-times" enterprise value to EBITDA. The analyst further states that Lumentum's competition in 3D is "slow to ramp", adding that he anticipates the approved Oclaro (OCLR) acquisition this year to yield up to $1 in earnings per share.
IIVI II-VI
$46.90

-0.15 (-0.32%)

08/27/18
DBAB
08/27/18
INITIATION
Target $58
DBAB
Buy
II-VI initiated with a Buy at Deutsche Bank
Deutsche Bank started II-VI with a Buy rating and $58 price target. The firm says the company offers "high growth" trading at a discounted valuation.
08/28/18
DBAB
08/28/18
INITIATION
Target $58
DBAB
Buy
Deutsche says II-VI growth not reflected in valuation, starts with Buy rating
Deutsche Bank analyst Sidney Ho last night initiated coverage of II-VI with a Buy rating and $58 price target. II-VI is a leader in engineered materials and optoelectronic components, Ho tells investors in a research note. The analyst believes the company's key growth drivers in the areas of silicon carbide, VCSEL and EUV lithography tools will complement steady growth in the laser and optics business, allowing II-VI to sustain a growth rate in the mid-teen percentages per year. This "solid growth trajectory" is not reflected in the stock's current valuation, Ho contends.
08/28/18
08/28/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. II-VI (IIVI) initiated with a Buy at Deutsche Bank while Cree (CREE) was initiated with a Hold. 2. Arlo Technologies (ARLO) initiated with an Outperform at Imperial Capital and Cowen, a Buy at Deutsche Bank, a Neutral at BofA/Merrill and Guggenheim, as well as a Market Perform at Raymond James. 3. AnaptysBio (ANAB) initiated with an Overweight at Cantor Fitzgerald. 4. Oshkosh (OSK) initiated with a Neutral at Buckingham. 5. nLight (LASR) initiated with a Sell at Benchmark. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/04/18
RILY
09/04/18
DOWNGRADE
Target $54
RILY
Neutral
II-VI downgraded to Neutral from Buy at B. Riley FBR
B. Riley FBR analyst Dave Kang downgraded II-VI to Neutral citing valuation and macro uncertainty. The analyst keeps a $54 price target for the shares. Kang this morning also downgraded Fabrinet (FN) citing a similar rationale.
ACIA Acacia Communications
$40.07

-0.1 (-0.25%)

08/24/18
08/24/18
DOWNGRADE
Target $37

Underperform
Acacia Communications downgraded to Underperform at BofA/Merrill
As previously reported, BofA/Merrill downgraded Acacia Communications to Underperform from Neutral and maintained a $37 price target. Analyst Tal Llani said shares have re-rated since the ZTE export ban and believes shares could underperform until investments pick-up in China.
08/24/18
BOFA
08/24/18
DOWNGRADE
BOFA
Underperform
Acacia Communications downgraded to Underperform from Neutral at BofA/Merrill
08/23/18
PIPR
08/23/18
UPGRADE
Target $26
PIPR
Overweight
Finisar upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Troy Jensen upgraded Finisar (FNSR) to Overweight from Neutral and raised his price target for the shares to $26 from $18. The shares closed yesterday down 95c, of 5%, to $18.65. China demand is returning via Huawei and ZTE (ZTCOY), Finisar is facing easy comps following five quarters of depressed demand and the upcoming 400G cycle should provide a tailwind in 2019, Jensen tells investors in a research note. On top of improving optical industry dynamics, the analyst believes Finisar's new CEO will improve the cost structure and execution at the company and drive better profitability. Now is a "great time" to revisit owning the shares, Jensen contends. The analyst this morning also upgraded Acacia Communications (ACIA) to Overweight from Neutral.
08/23/18
PIPR
08/23/18
UPGRADE
Target $46
PIPR
Overweight
Acacia Communications upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Troy Jensen upgraded Acacia Communications (ACIA) to Overweight and raised his price target for the shares to $46 from $38. Demand for optical is improving and Acacia is the best way to play the upcoming 400G cycle, Jensen tells investors in a research note. He believes the company's revenue growth will accelerate amid easy comps, improving demand from ZTE (ZTCOY), recent design wins and upcoming product cycles. Acacia can return to profitability levels seen before the China/ZTE slowdown, the analyst contends.

TODAY'S FREE FLY STORIES

AMZN

Amazon.com

$1,870.07

-0.23 (-0.01%)

, GRUB

GrubHub

$70.15

-2.76 (-3.79%)

13:28
06/15/19
06/15
13:28
06/15/19
13:28
Periodicals
Amazon exit gives GrubHub stock boost, Barron's says »

Amazon (AMZN) is…

AMZN

Amazon.com

$1,870.07

-0.23 (-0.01%)

GRUB

GrubHub

$70.15

-2.76 (-3.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 10

    Jul

ABC

AmerisourceBergen

$85.01

-1.46 (-1.69%)

, CAH

Cardinal Health

$44.16

-1.13 (-2.50%)

13:20
06/15/19
06/15
13:20
06/15/19
13:20
Periodicals
McKesson, Cardinal Health looking like bargains, Barron's says »

Investors have halved the…

ABC

AmerisourceBergen

$85.01

-1.46 (-1.69%)

CAH

Cardinal Health

$44.16

-1.13 (-2.50%)

MCK

McKesson

$133.19

-1.7 (-1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

RTN

Raytheon

$177.38

0.195 (0.11%)

, UTX

United Technologies

$125.30

0.45 (0.36%)

13:09
06/15/19
06/15
13:09
06/15/19
13:09
Periodicals
United Technologies, Raytheon stocks looking cheap, Barron's says »

Shares of United…

RTN

Raytheon

$177.38

0.195 (0.11%)

UTX

United Technologies

$125.30

0.45 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 17

    Jun

  • 17

    Jun

GRUB

GrubHub

$70.15

-2.76 (-3.79%)

, AMZN

Amazon.com

$1,870.07

-0.23 (-0.01%)

13:04
06/15/19
06/15
13:04
06/15/19
13:04
Periodicals
Food fight extending well beyond restaurant delivery, Barron's says »

Amazon (AMZN) is quitting…

GRUB

GrubHub

$70.15

-2.76 (-3.79%)

AMZN

Amazon.com

$1,870.07

-0.23 (-0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 10

    Jul

GOOGL

Alphabet Class A

$1,086.36

-4.65 (-0.43%)

, GOOG

Alphabet

$1,085.56

-3.52 (-0.32%)

12:59
06/15/19
06/15
12:59
06/15/19
12:59
Periodicals
Facebook, JPMorgan chiefs among Best CEOs of 2019, Barron's says »

Separated into three…

GOOGL

Alphabet Class A

$1,086.36

-4.65 (-0.43%)

GOOG

Alphabet

$1,085.56

-3.52 (-0.32%)

FB

Facebook

$181.35

3.88 (2.19%)

MCD

McDonald's

$205.33

0.85 (0.42%)

JPM

JPMorgan

$109.84

0.26 (0.24%)

BAC

Bank of America

$28.03

0.09 (0.32%)

BLK

BlackRock

$446.96

-1.29 (-0.29%)

BX

Blackstone

$44.13

0.17 (0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 19

    Jun

  • 09

    Jul

  • 10

    Jul

  • 16

    Jul

  • 17

    Jul

  • 06

    Aug

  • 27

    Oct

AVGO

Broadcom

$265.99

-15.96 (-5.66%)

, AAPL

Apple

$192.84

-1.93 (-0.99%)

07:17
06/15/19
06/15
07:17
06/15/19
07:17
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AVGO

Broadcom

$265.99

-15.96 (-5.66%)

AAPL

Apple

$192.84

-1.93 (-0.99%)

HNHPF

Hon Hai Precision

$0.00

(0.00%)

UTX

United Technologies

$125.30

0.45 (0.36%)

RTN

Raytheon

$177.38

0.195 (0.11%)

CGC

Canopy Growth

$41.15

-0.64 (-1.53%)

TLRY

Tilray

$38.96

-1.78 (-4.37%)

APHA

Aphria

$6.80

-0.15 (-2.16%)

ACB

Aurora Cannabis

$7.56

(0.00%)

CVSI

CV Sciences

$0.00

(0.00%)

CNTTF

CannTrust Holdings

$0.00

(0.00%)

CRON

Cronos Group

$15.43

-0.92 (-5.63%)

CANN

General Cannabis

$0.00

(0.00%)

IGC

India Globalization Capital

$1.28

0.4201 (48.85%)

MLCPF

MediPharm Labs

$0.00

(0.00%)

ZYNE

Zynerba

$13.03

-0.54 (-3.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 17

    Jun

  • 17

    Jun

  • 18

    Jun

  • 19

    Jun

  • 21

    Jun

  • 25

    Jun

  • 09

    Jul

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

, ABMD

Abiomed

$250.96

-4.58 (-1.79%)

04:55
06/15/19
06/15
04:55
06/15/19
04:55
Conference/Events
International League of Dermatological Societies to hold a conference »

24th World Congress of…

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

ABMD

Abiomed

$250.96

-4.58 (-1.79%)

BMY

Bristol-Myers

$47.57

0.25 (0.53%)

CELG

Celgene

$96.49

0.07 (0.07%)

LLY

Eli Lilly

$111.74

-0.06 (-0.05%)

JNJ

Johnson & Johnson

$140.08

-0.63 (-0.45%)

NVS

Novartis

$89.52

-0.07 (-0.08%)

PFE

Pfizer

$42.75

0.24 (0.56%)

PG

Procter & Gamble

$111.20

0.28 (0.25%)

SNY

Sanofi

$42.46

-0.225 (-0.53%)

UL

Unilever; also tag UN

$62.61

-0.07 (-0.11%)

UN

Unilever; also tag UL

$61.30

-0.13 (-0.21%)

INCY

Incyte

$77.76

1.385 (1.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 17

    Jun

  • 26

    Jun

  • 27

    Jun

  • 16

    Jul

  • 25

    Jul

  • 30

    Jul

  • 28

    Aug

  • 03

    Sep

  • 16

    Sep

  • 13

    Nov

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

BMY

Bristol-Myers

$47.57

0.25 (0.53%)

, GSK

GlaxoSmithKline

$40.12

0.015 (0.04%)

04:55
06/15/19
06/15
04:55
06/15/19
04:55
Conference/Events
European Congress of Rheumatology to hold a conference »

EULAR 2019 will be held…

BMY

Bristol-Myers

$47.57

0.25 (0.53%)

GSK

GlaxoSmithKline

$40.12

0.015 (0.04%)

PFE

Pfizer

$42.75

0.24 (0.56%)

LLY

Eli Lilly

$111.74

-0.06 (-0.05%)

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

NVS

Novartis

$89.52

-0.07 (-0.08%)

RHHBY

Roche

$0.00

(0.00%)

BIIB

Biogen

$227.67

-3.57 (-1.54%)

AMGN

Amgen

$176.09

-0.74 (-0.42%)

SNY

Sanofi

$42.46

-0.225 (-0.53%)

CELG

Celgene

$96.49

0.07 (0.07%)

GILD

Gilead

$66.38

-0.62 (-0.93%)

REGN

Regeneron

$305.19

-2.235 (-0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

  • 26

    Jun

  • 27

    Jun

  • 27

    Jun

  • 25

    Jul

  • 30

    Jul

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 26

    Aug

  • 28

    Aug

  • 29

    Aug

  • 02

    Sep

  • 03

    Sep

  • 16

    Sep

  • 04

    Nov

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

ABT

Abbott

$82.25

-0.03 (-0.04%)

, AMGN

Amgen

$176.09

-0.74 (-0.42%)

04:55
06/15/19
06/15
04:55
06/15/19
04:55
Conference/Events
Society for Vascular Surgery to hold annual meeting »

SVS Annual Meeting 2019…

ABT

Abbott

$82.25

-0.03 (-0.04%)

AMGN

Amgen

$176.09

-0.74 (-0.42%)

BSX

Boston Scientific

$40.41

-0.26 (-0.64%)

PFE

Pfizer

$42.75

0.24 (0.56%)

CRY

CryoLife

$29.13

-0.13 (-0.44%)

EW

Edwards Lifesciences

$184.00

-0.63 (-0.34%)

ELGX

Endologix

$7.61

0.2 (2.70%)

IAC

IAC

$228.41

-2.63 (-1.14%)

HCA

HCA Healthcare

$126.64

-0.76 (-0.60%)

LMAT

LeMaitre

$26.04

-0.44 (-1.66%)

ORGO

Organogenesis

$7.39

0.02 (0.27%)

OSIR

Osiris

$0.00

(0.00%)

PEN

Penumbra

$166.75

2.93 (1.79%)

SWAV

ShockWave Medical

$58.27

-0.99 (-1.67%)

WTKWY

Wolters Kluwer

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 26

    Jun

  • 09

    Aug

  • 26

    Aug

  • 26

    Aug

  • 28

    Aug

  • 16

    Sep

  • 25

    Sep

  • 13

    Nov

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

, INCY

Incyte

$77.76

1.385 (1.81%)

04:55
06/15/19
06/15
04:55
06/15/19
04:55
Conference/Events
European Hematology Association to hold a conference »

24th EHA Congress 2019…

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

INCY

Incyte

$77.76

1.385 (1.81%)

ARQL

ArQule

$8.17

1.88 (29.89%)

AMGN

Amgen

$176.09

-0.74 (-0.42%)

ALXN

Alexion

$117.94

0.65 (0.55%)

AGIO

Agios Pharmaceuticals

$47.97

-1.78 (-3.58%)

AZN

AstraZeneca

$39.68

-0.23 (-0.58%)

BLUE

Bluebird Bio

$117.57

-6.33 (-5.11%)

BMY

Bristol-Myers

$47.57

0.25 (0.53%)

CELG

Celgene

$96.49

0.07 (0.07%)

NVS

Novartis

$89.52

-0.07 (-0.08%)

NSTG

NanoString

$25.96

0.45 (1.76%)

KPTI

Karyopharm

$5.71

-0.04 (-0.70%)

JAZZ

Jazz Pharmaceuticals

$130.43

0.28 (0.22%)

GSK

GlaxoSmithKline

$40.12

0.015 (0.04%)

GILD

Gilead

$66.38

-0.62 (-0.93%)

DSNKY

Daiichi Sankyo

$0.00

(0.00%)

PFE

Pfizer

$42.75

0.24 (0.56%)

PTLA

Portola Pharmaceuticals

$25.78

-0.31 (-1.19%)

QGEN

Qiagen

$39.52

-0.07 (-0.18%)

RHHBY

Roche

$0.00

(0.00%)

RIGL

Rigel Pharmaceuticals

$2.06

-0.06 (-2.83%)

SNY

Sanofi

$42.46

-0.225 (-0.53%)

SGEN

Seattle Genetics

$68.67

-0.33 (-0.48%)

STML

Stemline

$14.20

0.12 (0.85%)

VSTM

Verastem

$1.39

0.125 (9.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jun

  • 17

    Jun

  • 18

    Jun

  • 20

    Jun

  • 20

    Jun

  • 20

    Jun

  • 21

    Jun

  • 23

    Jun

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 26

    Jun

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

  • 28

    Jun

  • 28

    Jun

  • 06

    Jul

  • 25

    Jul

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 26

    Aug

  • 28

    Aug

  • 29

    Aug

  • 02

    Sep

  • 03

    Sep

  • 16

    Sep

  • 04

    Nov

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

CNC

Centene

$53.52

-0.26 (-0.48%)

, WCG

WellCare

$287.16

0.145 (0.05%)

18:45
06/14/19
06/14
18:45
06/14/19
18:45
Hot Stocks
Centene CEO: Medicare for all will not work »

In an interview on…

CNC

Centene

$53.52

-0.26 (-0.48%)

WCG

WellCare

$287.16

0.145 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jun

  • 24

    Jun

  • 24

    Jun

  • 23

    Jul

HMC

Honda

$25.34

-0.405 (-1.57%)

18:24
06/14/19
06/14
18:24
06/14/19
18:24
Hot Stocks
Honda recalls all 2016-2019 model year Pioneer vehicles »

Honda is conducting a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RH

RH

$111.28

1.42 (1.29%)

18:22
06/14/19
06/14
18:22
06/14/19
18:22
Hot Stocks
RH CEO: We think our stock is massively undervalued »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DISH

Dish

$37.54

-0.35 (-0.92%)

, S

Sprint

$7.01

0.2 (2.94%)

18:08
06/14/19
06/14
18:08
06/14/19
18:08
Periodicals
Dish leads bidding for Sprint, T-Mobile assets, WSJ reports »

Dish Network (DISH) is…

DISH

Dish

$37.54

-0.35 (-0.92%)

S

Sprint

$7.01

0.2 (2.94%)

TMUS

T-Mobile

$74.90

0.44 (0.59%)

CHTR

Charter

$392.20

2.76 (0.71%)

ATUS

Altice USA

$23.82

0.15 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAL

American Airlines

$32.69

-0.39 (-1.18%)

17:31
06/14/19
06/14
17:31
06/14/19
17:31
Periodicals
American Air asks court to end 'devastating' work slowdown, Bloomberg says »

American Airlines urged a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROLL

RBC Bearings

$150.43

-3.38 (-2.20%)

17:16
06/14/19
06/14
17:16
06/14/19
17:16
Hot Stocks
RBC Bearings CEO sells over 5,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTNW

FTE Networks

$1.25

(0.00%)

17:14
06/14/19
06/14
17:14
06/14/19
17:14
Hot Stocks
FTE Networks granted financial viability exception by NYSE regulation »

FTE Networks announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$347.19

-1.54 (-0.44%)

17:14
06/14/19
06/14
17:14
06/14/19
17:14
Hot Stocks
Boeing awarded Air Force contract modification, increases ceiling by $6.53B »

Boeing has been awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 09

    Jul

MDR

McDermott

$7.60

-0.12 (-1.55%)

17:11
06/14/19
06/14
17:11
06/14/19
17:11
Hot Stocks
Chatterjee Fund Management reports 5.6% passive stake in McDermott »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PZZA

Papa John's

$50.74

0.28 (0.55%)

17:09
06/14/19
06/14
17:09
06/14/19
17:09
Hot Stocks
Papa John's dismisses KPMG as auditors, hires Ernst & Young »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 20

    Jun

  • 20

    Jun

  • 13

    Nov

EPZM

Epizyme

$11.62

-0.36 (-3.01%)

16:55
06/14/19
06/14
16:55
06/14/19
16:55
Conference/Events
Epizyme to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

CACI

CACI

$202.80

-1.205 (-0.59%)

16:54
06/14/19
06/14
16:54
06/14/19
16:54
Conference/Events
CACI to hold a conference call »

Management holds a fiscal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

HCR

Hi-Crush Inc.

$2.84

0.115 (4.22%)

16:53
06/14/19
06/14
16:53
06/14/19
16:53
Syndicate
Hi-Crush Inc files $1B mixed securities shelf »

The company also files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHIP

Seanergy Marine

$0.63

-0.0381 (-5.70%)

16:51
06/14/19
06/14
16:51
06/14/19
16:51
Earnings
Seanergy Marine reports Q1 EPS ($3.23), two estimates ($2.85) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FELP

Foresight Energy

$0.79

-0.04 (-4.82%)

16:46
06/14/19
06/14
16:46
06/14/19
16:46
Hot Stocks
Foresight Energy discloses NYSE listing standard notice »

Foresight Energy is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.